Dr Allameddine Allameddine

Consultant Haematologist

Dr Allameddine Allameddine is a consultant haematologist since 1994 who can provide expert evidence on malignant and non-malignant haematological cases, including bleeding and coagulation issues, transfusion and haematological laboratories.

Instructing Dr Allameddine Allameddine

If you want to instruct Dr Allameddine or if you want to discuss using Dr Allameddine for your case, please contact us.

Contact us

Profile

Dr Allameddine obtained his medical degree in 1990 in Italy, he then went on to achieve his specialist degree in haematology in 1994. Dr Allameddine is the Head of Department in Haematology since 2017, the Transfusion Lead and Chair of the Hospital Transfusion Committee for the Pennine Acute Trust since 2012 and the Training Lead for Pathology, for one of the largest DGH in the country, serving above 820.000 people, over 4 hospital sites.

Dr Allameddine is actively committed to education and training. He is Honorary Senior Lecturer in Manchester Medical School and covers the roles of Speciality Training Lead for Pathology in Pennine, Education Lead for Haematology and CS/ED for haematology and CMT trainees.

He has been awarded “Doctor of the year in 2014” and nominated for the “NHS Leadership Recognition Awards for the innovation”.

Specialist assessments offered

Dr Allameddine is an expert witness in malignant and non-malignant haematological disorders, including bleeding and coagulation issues, transfusion and haematological laboratories.

Publications

  1. The platelet function in mellitus diabetes (Medical degree thesis-1990).
  2. Autologus Stem Cell Transplantation in onco-haematologic malignancies (Specialist Degree thesis- 1994)
  1. “Alloimmunizzazione e refrattarietà alla terapia trasfusionale mediante concentrati piastrinici

in 40 pazienti affetti da neoplasie ematologiche”.

VIII Congresso Nazionale della Società Italiana di Emaferesi ed Autotrasfusione, Trieste 1997

  1. “Deplezione eritrocitaria del sangue di cordone ombelicale mediante amido idrossietilico:

confronto fra due metodiche”.

VIII Congresso Nazionale della Società Italiana di Emaferesi ed Autotrasfusione, Trieste 1997:

  1. The St. Eugenio Hospital Umbilical Cord Blood Banking Program: preliminary

results”.pubblicazione ufficiale della Società Internazionale di Ematologia, Cannes 1997:

  1. “Cryopreservation of umbilical cord blood using dimethyl sulfoxide and hydroxyethyl starch

without rate-controlled freezing”.pubblicazione ufficiale della Società Internazionale di

Ematologia, Cannes 1997:

  1. Autologus Peripheral Stem Cell Transplantation in LNH low-grade malignancies (Ph Degree

thesis- 1999)

  1. Piastrinopenia in gravidanza- linee guida per la diagnosi ed il trattamento.

Bollettino dell’ordine dei Medici Chirurghi e degli Odontoiatri della Provincia di Chieti. Anno

XIX. N. 3, luglio-settembre 2002

  1. “Portal vein thrombosis and deficit of proteins C and S. Digestive and Liver Disease. X

National Congress of Digestive Diseases Italian Federation of Digestive Diseases. Turin, 27-31

March 2004

  1. La gestione del paziente chirurgico a rischio trombo-embolico. Bollettino dell’ordine dei

Medici Chirurghi e degli Odontoiatri della Provincia di Chieti. Anno XXI. N. 1, Gennaio/Marzo

2005

  1. Ia gestione del rischio trombotico in gravidanza.Bollettino dell’ordine dei Medici Chirurghi e

degli Odontoiatri della Provincia di Chieti. Anno XXI. N. 2, Aprile/settembre 2005

  1. Conferenza: la gestione dei pazienti in trattamento anticoagulante. Convegno le malattie

ematologiche nell’adulto e nell’anziano. Vasto 19 maggio 2005

  1. Relazione convegno”Le vie del volontariato- giornata internazionale dei volontari ” Vasto

04/12/2005

  1. Thrombophilia screen in young patients with Ph negative chronic myeloproliferative

disorders (Paediatric Haematology Master thesis 2006)

  1. Inappropriate Use of Blood Transfusion in Obs & Gynae Departments in a Tertiary Care

Hospital and Potential Saving with Patient Blood Management (Abstract) . A. Allameddine

et all. British Blood Transfusion Society / NATA journal “Transfusion Medicine” (Transfusion

11

Medicine, 2014, 24, Suppl. 1). 15th Annual NATA Symposium, April 10-11, 2014 in Porto,

Portugal.

  1. Inappropriate Use of Blood Transfusion in Emergency Department in a Tertiary Care

Hospital and Potential Saving with Patient Blood Management (Abstract). A. Allameddine

et all. British Blood Transfusion Society / NATA journal “Transfusion Medicine” (Transfusion

Medicine, 2014, 24, Suppl. 1). 15th Annual NATA Symposium, April 10-11, 2014 in Porto,

Portugal.

  1. Analysis of Blood Wastage in a Tertiary Care Hospital in the Era of Patient Blood

Management (Abstract) . A. Allameddine et all. British Blood Transfusion Society / NATA

journal “Transfusion Medicine” (Transfusion Medicine, 2014, 24, Suppl. 1). 15th Annual NATA

Symposium, April 10-11, 2014 in Porto, Portugal.

  1. Chemotherapy-related mortality audit in haematology patients (Abstract). A. Allameddine.

The National Confidential Enquiry into Patient Outcome and Death (NCEPOD),

2014

  1. Reducing wastage level of paediatric blood units (Abstract). Dr A. Allameddine et all. British

Blood Transfusion Conference 2014

  1. An unavoidable case of TRALI (Abstract). Dr A. Allameddine et all. SHOT Symposium 2014,

Manchester, UK

  1. The impact of single-unit transfusion policy on Pennine Acute Trust blood usage (Article).

Dr A. Allameddine. Blood and Transplant Matters. Issue 43, October 2014

  1. Pennine Acute Trust’s initiatives on blood wastage (Abstract). Dr A. Allameddine et all. 16th

Annual NATA Symposium. Prague 2015

  1. The impact of single-unit transfusion policy on Pennine Acute Trust blood usage (Abstract).

Dr A. Allameddine. 16th Annual NATA Symposium. Prague 2015

  1. Single Unit Transfusion Policy for hospitalised patients without active bleeding; a Quality

Improvement Project (Abstract). Dr Allameddine (Consultant Haematologist), Dr Andrew

Tomkins (CMT 2). Conference Audit Research and Education, FGH 3rd July 2014

  1. A positive effect on haemochromatosis in patients with Rogers syndrome receiving

Deferasirox: a case report (Poster). Dr Allameddine. Myeloid Disorders Masterclass. London

03/10/2014

  1. Anaemia Management Service: The first pillar of the Patient Blood Management. Dr A.

Allameddine et all. 16th Annual NATA Symposium. Prague 2015

  1. The single-unit blood transfusion: Experience and impact in haematology patients.

Dr A. Allameddine et all. European Haematology Association.20th congress 2015, Vienna

  1. Audit on neonatal donor exposure: Dr A. Allameddine et all. International Society of Blood

Transfusion, held in London from June 27 – July 1, 2015.

  1. Audit on platelet transfusion As compared to the BCSH Guidelines (Audit ID: 2015 207),

presented at the NWRTC meeting, April 2016.

  1. Clinical Audit \Quality Improvement Project Action Plan: Re- audit, Safe Blood products

Transfusion: irradiation of blood components to prevent Transfusion- Associated Graft[1]versus-Host Disease, December 2015, presented at the NWRTC, April 2016

12

  1. Abstract on “The Blood Transfusion Performance in Pennine”: Dr A. Allameddine et all.

Presented at the Regional and National conference (IMPACT), Manchester June 2016

  1. Quality Improvement Project: “If you look for a thermometer, you will find a fever”: a

quality improvement project to reduce inappropriate blood tests amongst haematology

patients. Fisher, A, Khan, Z, Wijethileke, S, Allameddine, A. Presented at the Regional and

National conference (IMPACT), Manchester June 2016 (2016)

  1. Transforming the transfusion practice in Pennine Acute Trust, project presented to the HSJ

Awards, 2016

  1. The Single Unit Transfusion: The most effective and best transfusion practice, project

presented to the HSJ Awards, 2016

  1. Effect of Deferasirox Combined with Eryhtropoietin Versus Erythropoietin Alone on Eryhtroid

Response in Patients with Low and Int-1-Risk Myelodisplastic Syndromes: Results of the

Phase II KALLISTO Trial: N GAtterman, R Coll, L Jacobasch, A Allameddine, L DeBonnett, A

Azmon and J Jin, on behalf of the KALLISTO study investigators. Abstract accepted at ASH

2017

  1. Effect of Deferasirox Combined with Eryhtropoietin Versus Erythropoietin Alone on Eryhtroid

Response in Patients with Low and Int-1-Risk Myelodisplastic Syndromes: Results of the

Phase II KALLISTO Trial: N GAtterman, R Coll, L Jacobasch, A Allameddine, L DeBonnett, A

Azmon and J Jin, on behalf of the KALLISTO study investigators. European Journal of

Haematology, Volume101, Issue2, August 2018, Pages 208-215

  1. Fibrinogen monitoring and replacement in postpartum haemorrhage – An audit of current

practice at Pennine Acute Trust. Dr Jayne Peters, Dr Allameddine Allameddine. Abstract

submitted to BBTS 2018.

  1. Abstract Submission. Stem cell transplantation – Clinical. EHA-3841

ELDERLY PATIENTS WITH MULTIPLE MYELOMA:LONG-TERM OUTCOME FOLLOWING

INDUCTION WITH NOVEL DRUGS AND AUTOLOGOUS STEM CELL TRANSPLANT

Swabirah Rassool* 1, Lauren Foster1, Yonghan Li1, Saif Muhammad2, Antonina

Zhelyazkova3, Chetan Patalappa4, Simon Jowitt5, Patrick Carrington2, Hitesh Patel6,

Elizabeth Davies2, Pippa Bulger2, Muhammad Pervaiz3, Sarah Burns2, Camilo Humphrey2,

Naveeda Khaliq2, Allameddine Allameddine3, Sonya Ravenscroft5, Hayley Greenfield3,

Jennifer Frazer2, Wendy Ogden2, Eleni Tholouli2, Alberto Rocci2, 7

Availability

Dr Allameddine dedicates a couple of days a week to his medico-legal work.

Qualifications and memberships

Qualifications

MD, B/S Haem, Ph Haem, MS Pead, Haem, MS Haemost.Thromb

Professional memberships

Member of the Royal College of Pathologists

Member of the British Blood Transfusion Society

Member of the Medical Protection Society

Member of the British Medical Association

You can request to view the CV of any of our experts or contact us to discuss your requirements.